Acumen Pharmaceuticals Stock Buy Hold or Sell Recommendation
| ABOS Stock | USD 2.31 0.06 2.53% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Acumen Pharmaceuticals is 'Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Acumen Pharmaceuticals given historical horizon and risk tolerance towards Acumen Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Acumen Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Acumen Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Acumen Stock please use our How to Invest in Acumen Pharmaceuticals guide. Note, we conduct extensive research on individual companies such as Acumen and provide practical buy, sell, or hold advice based on investors' constraints. Acumen Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Acumen |
Execute Acumen Pharmaceuticals Buy or Sell Advice
The Acumen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Acumen Pharmaceuticals. Macroaxis does not own or have any residual interests in Acumen Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Acumen Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Acumen Pharmaceuticals Trading Alerts and Improvement Suggestions
| Acumen Pharmaceuticals generated a negative expected return over the last 90 days | |
| Acumen Pharmaceuticals has high historical volatility and very poor performance | |
| Acumen Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (52.37 M) with loss before overhead, payroll, taxes, and interest of (32.36 M). | |
| Acumen Pharmaceuticals currently holds about 189.91 M in cash with (43.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.69, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Acumen Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 78.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Acumen Pharmaceuticals Posts Earnings Results, Misses Estimates By 0.14 EPS |
Acumen Pharmaceuticals Returns Distribution Density
The distribution of Acumen Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Acumen Pharmaceuticals' future price movements. The chart of the probability distribution of Acumen Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Acumen Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Acumen Pharmaceuticals returns is essential to provide solid investment advice for Acumen Pharmaceuticals.
| Mean Return | -0.16 | Value At Risk | -6.67 | Potential Upside | 7.52 | Standard Deviation | 4.69 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Acumen Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Acumen Stock Institutional Investors
The Acumen Pharmaceuticals' institutional investors refer to entities that pool money to purchase Acumen Pharmaceuticals' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Alyeska Investment Group, L.p. | 2024-06-30 | 939.6 K | Geode Capital Management, Llc | 2024-06-30 | 812.1 K | Hudson Bay Capital Management Lp | 2024-06-30 | 670 K | Pathstone Holdings Llc | 2024-06-30 | 480.2 K | State Street Corp | 2024-06-30 | 436.6 K | Jane Street Group Llc | 2024-06-30 | 427.7 K | Two Sigma Advisers, Llc | 2024-06-30 | 392.1 K | Two Sigma Investments Llc | 2024-06-30 | 310.8 K | Northern Trust Corp | 2024-09-30 | 308.9 K | Ra Capital Management, Llc | 2024-06-30 | 14.9 M | Sands Capital Ventures, Llc | 2024-09-30 | 3.4 M |
Acumen Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Acumen Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Acumen Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Acumen stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.43 | |
β | Beta against Dow Jones | 3.10 | |
σ | Overall volatility | 4.74 | |
Ir | Information ratio | -0.05 |
Acumen Pharmaceuticals Volatility Alert
Acumen Pharmaceuticals exhibits very low volatility with skewness of -0.39 and kurtosis of 1.82. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Acumen Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Acumen Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Acumen Pharmaceuticals Fundamentals Vs Peers
Comparing Acumen Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Acumen Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Acumen Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Acumen Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Acumen Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Acumen Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Acumen Pharmaceuticals to competition |
| Fundamentals | Acumen Pharmaceuticals | Peer Average |
| Return On Equity | -0.33 | -0.31 |
| Return On Asset | -0.21 | -0.14 |
| Current Valuation | (29.49 M) | 16.62 B |
| Shares Outstanding | 60.08 M | 571.82 M |
| Shares Owned By Insiders | 11.23 % | 10.09 % |
| Shares Owned By Institutions | 78.49 % | 39.21 % |
| Number Of Shares Shorted | 1.45 M | 4.71 M |
| Price To Book | 0.66 X | 9.51 X |
| Price To Sales | 538.78 X | 11.42 X |
| Gross Profit | (32.36 M) | 27.38 B |
| EBITDA | (51.61 M) | 3.9 B |
| Net Income | (52.37 M) | 570.98 M |
| Cash And Equivalents | 189.91 M | 2.7 B |
| Cash Per Share | 4.69 X | 5.01 X |
| Total Debt | 28.49 M | 5.32 B |
| Current Ratio | 37.21 X | 2.16 X |
| Book Value Per Share | 3.62 X | 1.93 K |
| Cash Flow From Operations | (43.06 M) | 971.22 M |
| Short Ratio | 7.19 X | 4.00 X |
| Earnings Per Share | (1.38) X | 3.12 X |
| Price To Earnings To Growth | (0.23) X | 4.89 X |
| Target Price | 10.8 | |
| Number Of Employees | 51 | 18.84 K |
| Beta | 0.039 | -0.15 |
| Market Capitalization | 142.39 M | 19.03 B |
| Total Asset | 310.12 M | 29.47 B |
| Retained Earnings | (222.8 M) | 9.33 B |
| Working Capital | 233.64 M | 1.48 B |
| Net Asset | 310.12 M |
Note: Insider Trading [view details]
Acumen Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Acumen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Acumen Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Acumen Pharmaceuticals? Buying financial instruments such as Acumen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Acumen Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Drugs Thematic Idea Now
Drugs
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.